{"id":152269,"date":"2023-08-10T05:48:51","date_gmt":"2023-08-10T09:48:51","guid":{"rendered":"https:\/\/44.250.171.167\/?p=152269"},"modified":"2023-08-10T05:48:53","modified_gmt":"2023-08-10T09:48:53","slug":"kopran-ltd-q1fy24-64-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/kopran-ltd-q1fy24-64-fall-in-profits\/","title":{"rendered":"Kopran Ltd Q1FY24; 64% fall in Profits"},"content":{"rendered":"<p>Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide.<\/p>\n<p><br \/><strong>Financial Results:<\/strong><\/p>\n<ul>\n<li>Kopran Ltd reported Revenues for Q1FY24 of \u20b9117.00 Crores down from \u20b9125.62 Crore year on year, a fall of 6.86%.<\/li>\n<li>Total Expenses for Q1FY24 of \u20b9115.78 Crores down from \u20b9116.30 Crores year on year, a fall of 0.45%.<\/li>\n<li>Consolidated Net Profit of \u20b92.77 Crores down 63.55% from \u20b97.60 Crores in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b90.57, down 63.92% from \u20b91.58 in the same quarter of the previous year.<\/li>\n<\/ul>\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533-839x1024.png\" alt=\"\" class=\"wp-image-152270\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide. Financial Results: Kopran Ltd reported Revenues for Q1FY24 of \u20b9117.00 Crores down from \u20b9125.62 Crore year on year, a fall of 6.86%. Total Expenses for Q1FY24 of \u20b9115.78 Crores down from \u20b9116.30 Crores year on [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[1115],"class_list":["post-152269","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":153880,"url":"https:\/\/alphastreet.com\/india\/venus-remedies-ltd-q1fy24-83-fall-in-profits\/","url_meta":{"origin":152269,"position":0},"title":"Venus Remedies Ltd Q1FY24; 83% fall in Profits","author":"Chirag Gupta","date":"August 14, 2023","format":false,"excerpt":"Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical products manufacturing. Financial Results: Venus Remedies Ltd reported Revenues for Q1FY24 of \u20b995.15 Crores down from \u20b9143.08 Crore year on year, a fall of 33.5%.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":153153,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q1fy24-18-fall-in-profits\/","url_meta":{"origin":152269,"position":1},"title":"Glenmark Pharmaceuticals Ltd Q1FY24; 18% fall in Profits","author":"Hardik Bhandare","date":"August 14, 2023","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Glenmark Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b93,402.00 Crores up from \u20b92,777.00 Crore year on year, a rise of 22.51%. Total Expenses for Q1FY24\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-823.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150857,"url":"https:\/\/alphastreet.com\/india\/lyka-labs-ltd-q1fy24-17-fall-in-revenue\/","url_meta":{"origin":152269,"position":2},"title":"Lyka Labs Ltd Q1FY24; 17% fall in Revenue","author":"Karan_Singh","date":"August 2, 2023","format":false,"excerpt":"Lyka labs Ltd is a pharmaceutical company engaged in development, manufacturing and marketing of pharmaceutical products. It has a well-diversified business model in terms of markets, therapies and products.It is one of the oldest company in the Indian Pharmaceutical Industry having presence in Domestic and International markets. Financial Results: Lyka\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152487,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-q1fy24-8-fall-in-revenue\/","url_meta":{"origin":152269,"position":3},"title":"Brooks Laboratories Ltd Q1FY24; 8% fall in Revenue","author":"Divyansh_Kasana","date":"August 10, 2023","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical manufacturing company primarily working on contract basis. Financial Results: Brooks Laboratories Ltd reported Revenues for Q1FY24 of \u20b915.70 Crores down from \u20b917.12 Crore year on year, a fall of 8.29%. Total Expenses for Q1FY24 of \u20b920.22 Crores down from \u20b928.32 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154118,"url":"https:\/\/alphastreet.com\/india\/ind-swift-laboratories-ltd-q1fy24-15-fall-in-profits\/","url_meta":{"origin":152269,"position":4},"title":"Ind-Swift Laboratories Ltd Q1FY24; 15% fall in Profits","author":"Hardik Bhandare","date":"August 16, 2023","format":false,"excerpt":"Incorporated in 1995, Ind-Swift Laboratories Ltd is engaged in the manufacturing of Active Pharmaceutical Ingredients(APIs), and Advanced Intermediates, and providing Contract Research and Manufacturing Services (CRAMS). Financial Results: Ind-Swift Laboratories Ltd reported Revenues for Q1FY24 of \u20b9310.00 Crores up from \u20b9280.00 Crore year on year, a rise of 10.71%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1138.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1138.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1138.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1138.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1138.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1138.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154139,"url":"https:\/\/alphastreet.com\/india\/bajaj-healthcare-ltd-q1fy24-21-fall-in-revenue\/","url_meta":{"origin":152269,"position":5},"title":"Bajaj Healthcare Ltd Q1FY24; 21% fall in Revenue","author":"Divyansh_Kasana","date":"August 16, 2023","format":false,"excerpt":"Established in the year 1993, Bajaj Healthcare Ltd is an estalished player in the Indian Pharmacuetical Industry and fastest growing mid-cap pharmaceutical companies in India. Financial Results: Bajaj Healthcare Ltd reported Revenues for Q1FY24 of \u20b9130.00 Crores down from \u20b9164.00 Crore year on year, a fall of 20.73%. Total Expenses\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1145.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1145.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1145.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1145.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1145.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1145.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=152269"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152269\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=152269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=152269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=152269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}